Virginia Retirement Systems Et Al Avrobio, Inc. Transaction History

Virginia Retirement Systems Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$3.45 - $6.05 $149,385 - $261,965	-43,300 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$5.53 - $9.28 $91,798 - $154,048	16,600 Added 62.17%	43,300 $242,000
Q2 2021 Aug 13, 2021	BUY	$7.84 - $12.6 $62,720 - $100,800	8,000 Added 42.78%	26,700 $237,000
Q1 2021 Apr 30, 2021	BUY	$10.54 - $19.3 $197,097 - $360,910	18,700 New	18,700 $237,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.